TY - JOUR
T1 - A high-throughput fluorescence screen to monitor the specific binding of antagonists to RNA targets
AU - Hamasaki, Keita
AU - Rando, Robert R.
N1 - Funding Information:
These studies were partially funded by U.S. Public Health Service National Institutes of Health Grants EY-03624 and EY-04096. K.H. was funded by a research fellowship from the Japan Society for the Promotion of Science.
PY - 1998/8/1
Y1 - 1998/8/1
N2 - Since RNA molecules can form intricate three-dimensional structures, it should be possible to design specific, high-affinity antagonists directed against these structures. To begin to explore the validity of this possibility, high-throughput screening methods are required to assay for RNA antagonists. A fluorescence quenching technique is described here in a 96- well plate format which is capable of screening chemical diversity libraries. A pyrene-containing aminoglycoside analog is used to accurately monitor antagonist binding to a prokaryotic 16S rRNA A-site decoding region construct. This rRNA region comprises the natural target for aminoglycoside antibiotics. The fluorescence technique reported here should be generally adaptable to monitor the binding of structurally novel antagonists to any selected RNA target.
AB - Since RNA molecules can form intricate three-dimensional structures, it should be possible to design specific, high-affinity antagonists directed against these structures. To begin to explore the validity of this possibility, high-throughput screening methods are required to assay for RNA antagonists. A fluorescence quenching technique is described here in a 96- well plate format which is capable of screening chemical diversity libraries. A pyrene-containing aminoglycoside analog is used to accurately monitor antagonist binding to a prokaryotic 16S rRNA A-site decoding region construct. This rRNA region comprises the natural target for aminoglycoside antibiotics. The fluorescence technique reported here should be generally adaptable to monitor the binding of structurally novel antagonists to any selected RNA target.
UR - http://www.scopus.com/inward/record.url?scp=0032144561&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032144561&partnerID=8YFLogxK
U2 - 10.1006/abio.1998.2740
DO - 10.1006/abio.1998.2740
M3 - Article
C2 - 9716420
AN - SCOPUS:0032144561
SN - 0003-2697
VL - 261
SP - 183
EP - 190
JO - Analytical Biochemistry
JF - Analytical Biochemistry
IS - 2
ER -